132 related articles for article (PubMed ID: 32670273)
1. Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
Naz F; Arish M
Front Immunol; 2020; 11():1102. PubMed ID: 32670273
[TBL] [Abstract][Full Text] [Related]
2. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
McGowan EM; Haddadi N; Nassif NT; Lin Y
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
[TBL] [Abstract][Full Text] [Related]
3. Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus.
Zhao J; Zhu M; Jiang H; Shen S; Su X; Shi Y
Sci Rep; 2019 Mar; 9(1):5272. PubMed ID: 30918324
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
Meacci E; Garcia-Gil M; Pierucci F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942748
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
6. Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection.
Pan Y; Gao F; Zhao S; Han J; Chen F
Clin Exp Pharmacol Physiol; 2021 May; 48(5):637-650. PubMed ID: 33565127
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
Benani A; Ben Mkaddem S
Front Immunol; 2020; 11():1841. PubMed ID: 32793246
[TBL] [Abstract][Full Text] [Related]
8. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
Liu YM; Shahed-Al-Mahmud M; Chen X; Chen TH; Liao KS; Lo JM; Wu YM; Ho MC; Wu CY; Wong CH; Jan JT; Ma C
Cell Rep; 2020 Aug; 32(6):108016. PubMed ID: 32755598
[TBL] [Abstract][Full Text] [Related]
9. Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy.
Matheu MP; Teijaro JR; Walsh KB; Greenberg ML; Marsolais D; Parker I; Rosen H; Oldstone MB; Cahalan MD
PLoS One; 2013; 8(3):e58033. PubMed ID: 23533579
[TBL] [Abstract][Full Text] [Related]
10. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
Blaess M; Kaiser L; Sauer M; Csuk R; Deigner HP
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668803
[TBL] [Abstract][Full Text] [Related]
11. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.
Walsh KB; Teijaro JR; Wilker PR; Jatzek A; Fremgen DM; Das SC; Watanabe T; Hatta M; Shinya K; Suresh M; Kawaoka Y; Rosen H; Oldstone MB
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12018-23. PubMed ID: 21715659
[TBL] [Abstract][Full Text] [Related]
12. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: Stay Cool toward Corticosteroids.
Fujishima S
Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
[No Abstract] [Full Text] [Related]
15. Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
Smetana K; Rosel D; BrÁbek J
In Vivo; 2020; 34(5):3027-3028. PubMed ID: 32871847
[TBL] [Abstract][Full Text] [Related]
16. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
Theoharides TC
Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
[No Abstract] [Full Text] [Related]
17. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
18. Teaching Old Drugs New Tricks: Statins for COVID-19?
Fajgenbaum DC; Rader DJ
Cell Metab; 2020 Aug; 32(2):145-147. PubMed ID: 32755604
[TBL] [Abstract][Full Text] [Related]
19. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
[TBL] [Abstract][Full Text] [Related]
20. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
